Concomitantly, NASH fosters the hepatic enrichment of tumour-associated macrophages (TAMs) displaying a high expression of PD-L1 that by binding to PD-1 on effector T cells transduces immunosuppressive signals [122] (Figure 2). The gene discussed is PDCD1; the disease is neoplasm.